This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2001-2006.
Company Filing History:
Years Active: 2001-2006
Title: Thomas Walsh: Innovator in Adrenomedullin Research
Introduction
Thomas Walsh is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of human pathology and physiology through his innovative research. With a total of 2 patents, Walsh's work focuses on the functional role of adrenomedullin (AM) and its implications in cancer and pancreatic physiology.
Latest Patents
Walsh's latest patents include groundbreaking methods that demonstrate the expression of adrenomedullin in human cancer cell lines. His research indicates that AM acts as a universal autocrine growth factor that drives neoplastic proliferation. The patents provide AM peptides and antibodies that are useful in therapeutic, pharmacologic, and physiologic compositions. Additionally, they outline methods for the diagnosis, treatment, and prevention of diseases utilizing these compositions. Notably, his research has shown that AM inhibits insulin secretion in a dose-dependent manner, and the monoclonal antibody MoAb-G6, which neutralizes AM bioactivity, significantly increases insulin release.
Career Highlights
Thomas Walsh is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to explore the complexities of adrenomedullin and its potential therapeutic applications.
Collaborations
Walsh has collaborated with esteemed colleagues such as Alfredo Martinez and Mae Jean Miller. Their combined expertise has further advanced the understanding of adrenomedullin's role in human health.
Conclusion
Thomas Walsh's innovative research on adrenomedullin has the potential to transform therapeutic approaches in treating various diseases. His contributions to science exemplify the impact of dedicated inventors in advancing medical knowledge and improving patient outcomes.